Does GLATIRAMER Cause Off label use? 171 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 171 reports of Off label use have been filed in association with GLATIRAMER (GLATIRAMER ACETATE). This represents 0.4% of all adverse event reports for GLATIRAMER.
171
Reports of Off label use with GLATIRAMER
0.4%
of all GLATIRAMER reports
2
Deaths
23
Hospitalizations
How Dangerous Is Off label use From GLATIRAMER?
Of the 171 reports, 2 (1.2%) resulted in death, 23 (13.5%) required hospitalization, and 1 (0.6%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GLATIRAMER. However, 171 reports have been filed with the FAERS database.
What Other Side Effects Does GLATIRAMER Cause?
Injection site pain (5,003)
Multiple sclerosis relapse (3,695)
Drug ineffective (3,321)
Injection site reaction (3,317)
Multiple sclerosis (2,596)
Injection site erythema (2,560)
Fatigue (2,408)
Dyspnoea (2,364)
Injection site mass (2,172)
Injection site swelling (1,836)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which GLATIRAMER Alternatives Have Lower Off label use Risk?
GLATIRAMER vs GLECAPREVIR\PIBRENTASVIR
GLATIRAMER vs GLEEVEC
GLATIRAMER vs GLICLAZIDE
GLATIRAMER vs GLIMEPIRIDE
GLATIRAMER vs GLIMEPIRIDE\ROSIGLITAZONE